ELOCP26

Across TCGA pan-cancer cohorts, ELOCP26 RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated ELOCP26 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher ELOCP26 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ELOCP26 expression acts as an unfavorable survival marker, although some lineages such as OV show a favorable association.

STAD, KIRP, and OV are the cancer types where ELOCP26 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	III,IV	0.089	0.590	<.001	63	view →
KIRP	DFS	Tertile	III,IV	0.191	0.720	.003	27	view →
OV	OS	Tertile	III,IV	0.818	0.309	.032	12	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

ELOCP26–STAD (DFS)

Open the STAD breakdown →